Comparative Effectiveness of Anti-Inflammatory Drug Treatments in Coronary Heart Disease Patients: A Systematic Review and Network Meta-Analysis

Table 2

Patient population and clinical scenario among included studies.

Patient population	Study	Investigational drug
STEMI	APEX-MI [28]	Pexelizumab
	COMMA [16]
	COMPLY [16]
	VCU-ART3 [34]	Anakinra
NSTEMI	MRC-ILA Heart Study [35]	Anakinra
MI (STEMI and NSTEMI)	CANTOS [17]	Canakinumab
	LATITUDE TIMI 60 [43]	Losmapimod
	COLCOT [37]	Colchicine
ACS (STEMI, NSTEMI, or UA)	SOLID TIMI 52 [38]	Darapladib
	FRANCIS [41]	Varespladib
	VISTA-16 [40]	Varespladib
CABG	PRIMO CABG 1 [32]	Pexelizumab
	PRIMO CABG 2 [31]
	Pexelizumab Study Investigators [30]
	SELECT-CABG [42]	Inclacumab
Stable CAD	STABILITY [39]	Darapladib
	LoDoCo [36]	Colchicine

Study with subgroup analysis of its primary end points.